Loading clinical trials...
Loading clinical trials...
Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control During an Intensively Monitored Antiretroviral Pause (IMAP)
Conditions
Interventions
Antiretroviral treatment pause
Locations
18
United States
601 University of California, Los Angeles CARE Center CRS
Los Angeles, California, United States
701 University of California, San Diego AntiViral Research Center CRS
San Diego, California, United States
801 University of California, San Francisco HIV/AIDS CRS
San Francisco, California, United States
University of Colorado Hospital CRS (6101)
Aurora, Colorado, United States
Whitman Walker Health CRS (31791)
Washington D.C., District of Columbia, United States
2701 Northwestern University CRS
Chicago, Illinois, United States
Start Date
February 23, 2017
Primary Completion Date
January 29, 2021
Completion Date
January 29, 2021
Last Updated
December 13, 2024
NCT06660498
NCT06602622
NCT05729568
NCT06185452
NCT06902038
NCT04568603
Lead Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions